Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
31.86
+0.77 (2.48%)
At close: Aug 20, 2026, 4:00 PM EDT
31.91
+0.05 (0.16%)
Pre-market: Aug 21, 2026, 9:28 AM EDT

Hims & Hers Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-142.03128.37126.04-23.55-65.68-107.66
Depreciation & Amortization
87.1954.517.099.527.474.08
Other Amortization
7.144.53---0.14
Asset Writedown & Restructuring Costs
30.140.530.110.431.13-
Loss (Gain) From Sale of Investments
-0.8-6.47-4.36-5.690.152.17
Stock-Based Compensation
153.64135.2492.3266.0842.8267.21
Other Operating Activities
48.3812.47-58.755.871.78-3.8
Change in Inventory
49.4-13.72-41.61-0.9-8-9.63
Change in Accounts Payable
348.9530.343.717.3212.729.85
Change in Unearned Revenue
31.4351.667.556.26-1.721.41
Change in Other Net Operating Assets
-21.65-97.348.978.14-17.21.82
Operating Cash Flow
263.45300.01251.0873.48-26.53-34.41
Operating Cash Flow Growth
0.70%19.48%241.69%---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-180.42-226.05-41.66-17.22-2.71-0.83
Cash Acquisitions
-458.24-145.23-15.4--0.46-46.47
Sale (Purchase) of Intangibles
-21.39-16.55-11.1-9.27-4.53-4.18
Investment in Securities
-241.93-637.1449.114.3942.41-104.79
Investing Cash Flow
-901.98-1,025-19.05-12.1134.7-156.27

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-970----
Net Debt Issued (Repaid)
390.43970----
Issuance of Common Stock
24.8817.4730.894.623.42275.92
Repurchase of Common Stock
-206.48-206.63-135.54-16.1-3.9-28.03
Other Financing Activities
-81.48-51.22-3.19--32.65-12.85
Financing Cash Flow
127.35729.62-107.85-11.48-33.13235.04

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-3.952.51-0.27-0.01-0.05-0.07
Net Cash Flow
-515.147.18123.9249.89-25.0144.29

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
83.0373.96209.4356.26-29.25-35.24
Free Cash Flow Growth
-37.28%-64.68%272.23%---
Free Cash Flow Margin
3.22%3.15%14.18%6.45%-5.55%-12.96%
Free Cash Flow Per Share
0.360.290.880.27-0.14-0.19
Levered Free Cash Flow
849.44110.51178.6266.38-44.3552.46
Unlevered Free Cash Flow
848.13108.42178.6266.38-44.3552.32

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1.74-----
Cash Income Tax Paid
-23.167.921.110.640.34
Change in Working Capital
79.79-29.1678.6220.82-14.23.46
SEC Filings: 10-K · 10-Q